Biomarker and diagnostic research for recessive dystrophic epidermolysis bullosa-generalized other has been reported in the published literature.

2 FDA-approved treatments are available for recessive dystrophic epidermolysis bullosa-generalized other, including Prademagene zamikeracel (zevaskyn, approved 2025) and beremagene geperpavec-svdt (VYJUVEK, approved 2023).

Approved Therapies

Gene therapy approaches for recessive dystrophic epidermolysis bullosa-generalized other have been reported in the published literature.

Phenotype severity distribution: 7 very common features, 21 common features.

Estimated prevalence: Unknown (Unknown prevalence).

No clinical trials have been registered for recessive dystrophic epidermolysis bullosa-generalized other.

45 publications have been identified in PubMed for recessive dystrophic epidermolysis bullosa-generalized other. Research spans Clinical Trial Publication (20%), Review / Meta-Analysis (18%), and Case Report / Case Series (16%).

Recent Publications

• Biggs K (2026). [PMID: 42237200](https://pubmed.ncbi.nlm.nih.gov/42237200/). *Orphanet J Rare Dis*. [Clinical Trial Publication]

• Iwamoto T (2026). [PMID: 41982580](https://pubmed.ncbi.nlm.nih.gov/41982580/). *Cureus*. [Case Report / Case Series]

• Jeffs E (2026). [PMID: 42087161](https://pubmed.ncbi.nlm.nih.gov/42087161/). *Orphanet J Rare Dis*. [Epidemiology / Natural History]

• Den S (2026). [PMID: 42123236](https://pubmed.ncbi.nlm.nih.gov/42123236/). *J Clin Med*. [Case Report / Case Series]

• von Gunten M (2026). [PMID: 41966929](https://pubmed.ncbi.nlm.nih.gov/41966929/). *J Hand Ther*. [Case Report / Case Series]

• Feinstein JA (2026). [PMID: 41735025](https://pubmed.ncbi.nlm.nih.gov/41735025/). *Pediatric dermatology*. [Review / Meta-Analysis]

• Gretzmeier C (2026). [PMID: 42147441](https://pubmed.ncbi.nlm.nih.gov/42147441/). *Mol Ther Adv*. [Gene Therapy / Novel Therapeutics]

• Dette CMU (2025). [PMID: 41404110](https://pubmed.ncbi.nlm.nih.gov/41404110/). *Computational and structural biotechnology journal*. [Review / Meta-Analysis]

• Osborn MJ (2025). [PMID: 40077969](https://pubmed.ncbi.nlm.nih.gov/40077969/). *Molecular therapy : the journal of the American Society of Gene Therapy*. [Review / Meta-Analysis]

• Mellerio JE (2025). [PMID: 39874247](https://pubmed.ncbi.nlm.nih.gov/39874247/). *Clinical and experimental dermatology*. [Epidemiology / Natural History]